EUPATI Webinar on Patient Experience in HTA

Error message

  • Deprecated function: TYPO3\PharStreamWrapper\Manager::initialize(): Implicitly marking parameter $resolver as nullable is deprecated, the explicit nullable type must be used instead in include_once() (line 19 of includes/file.phar.inc).
  • Deprecated function: TYPO3\PharStreamWrapper\Manager::initialize(): Implicitly marking parameter $collection as nullable is deprecated, the explicit nullable type must be used instead in include_once() (line 19 of includes/file.phar.inc).
  • Deprecated function: TYPO3\PharStreamWrapper\Manager::__construct(): Implicitly marking parameter $resolver as nullable is deprecated, the explicit nullable type must be used instead in include_once() (line 19 of includes/file.phar.inc).
  • Deprecated function: TYPO3\PharStreamWrapper\Manager::__construct(): Implicitly marking parameter $collection as nullable is deprecated, the explicit nullable type must be used instead in include_once() (line 19 of includes/file.phar.inc).

EUPATI Webinar on Patient Experience in HTA

Tuesday, 26 September 2017

The webinar will focus on listening to patients relating their experience when going through Health Technology assessment (HTA) processes. Two EUPATI Fellows, Paola Kruger (Italy) and Joan Jordan (Ireland) will share their experience. In Joan Jordan's case we will also have the point of view of the pharmaceutical industry involved in this specific HTA process as two representatives from Roche, David McCarthy and Colm Fahey will participate in the discussion.

This is a great opportunity to join the discussions, share your perspective and ask your questions in the Q&A session

 

AGENDA 17.00   

Welcome and introductions - Tamás Bereczky, EATG

17.05  

Patients Experience in HTA processes: Paola Kruger, EUPATI Fellow, Joan Jordan, EUPATI Fellow, David McCarthy, Roche and Colm Fahey, Roche

17.30   

Q & A – Moderator: Tamás Bereczky, EATG

Panel members: Paola Kruger, EUPATI Fellow, Joan Jordan, EUPATI Fellow, David McCarthy, Roche and Colm Fahey, Roche

18.30   

Close of the Webinar